Back to News
Market Impact: 0.2

Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips

Market Technicals & FlowsInvestor Sentiment & PositioningCompany Fundamentals
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips

Moderna shares fell 18% to $142.70 in Thursday midday trading, reversing part of Wednesday’s outsized 177% rally. The move suggests profit-taking/mean reversion after a historically large jump rather than new fundamentals in the headline.

Analysis

Moderna shares fell 18% to $142.70 in Thursday midday trading, reversing part of Wednesday’s outsized 177% rally. The move suggests profit-taking/mean reversion after a historically large jump rather than new fundamentals in the headline.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.25

Ticker Sentiment

MRNA-0.45

More News